R01 CA174735/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Save citations to file

Email citations

Subject: R01 CA174735/CA/NCI NIH HHS/United States[Grant N - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2015	3
2016	8
2017	8
2018	5
2019	3
2020	2
2021	1
2023	0

29 results

Page of 1

Results by year

Page 1

DNAJA1 promotes cancer metastasis through interaction with mutant p53.

Kaida A, Yamamoto S, Parrales A, Young ED, Ranjan A, Alalem MA, Morita KI, Oikawa Y, Harada H, Ikeda T, Thomas SM, Diaz FJ, Iwakuma T. Kaida A, et al. Oncogene. 2021 Aug;40(31):5013-5025. doi: 10.1038/s41388-021-01921-3. Epub 2021 Jun 28. Oncogene. 2021. PMID: 34183772 Free PMC article.

TAp63-miRNA-AURKA Axis as a Therapeutic Target for Cutaneous Squamous Cell Carcinoma.

Parrales A, Iwakuma T. Parrales A, et al. Cancer Res. 2020 Jun 15;80(12):2439-2440. doi: 10.1158/0008-5472.CAN-20-1215. Cancer Res. 2020. PMID: 32540854 Free PMC article.

Suppressing STAT5 signaling affects osteosarcoma growth and stemness.

Subramaniam D, Angulo P, Ponnurangam S, Dandawate P, Ramamoorthy P, Srinivasan P, Iwakuma T, Weir SJ, Chastain K, Anant S. Subramaniam D, et al. Cell Death Dis. 2020 Feb 24;11(2):149. doi: 10.1038/s41419-020-2335-1. Cell Death Dis. 2020. PMID: 32094348 Free PMC article.

The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.

Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, Sayed AAA, Choudhury S, Standing D, Subramaniam D, Padhye SB, Gunewardena S, Thomas SM, Neil MO, Tawfik O, Welch DR, Jensen RA, Maliski S, Weir S, Iwakuma T, Anant S, Dhar A. Dandawate P, et al. Gastroenterology. 2019 Dec;157(6):1646-1659.e11. doi: 10.1053/j.gastro.2019.08.018. Epub 2019 Aug 20. Gastroenterology. 2019. PMID: 31442435 Free PMC article.

TP53 in bone and soft tissue sarcomas.

Thoenen E, Curl A, Iwakuma T. Thoenen E, et al. Pharmacol Ther. 2019 Oct;202:149-164. doi: 10.1016/j.pharmthera.2019.06.010. Epub 2019 Jul 2. Pharmacol Ther. 2019. PMID: 31276706 Free PMC article. Review.

Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation.

Han Y, Wu P, Wang Z, Zhang Z, Sun S, Liu J, Gong S, Gao P, Iwakuma T, Molina-Vila MA, Chen BP, Zhang Y, Ji T, Mo Q, Chen P, Hu J, Wang S, Zhou J, Lu H, Gao Q. Han Y, et al. EBioMedicine. 2019 Feb;40:92-105. doi: 10.1016/j.ebiom.2019.01.002. Epub 2019 Jan 20. EBioMedicine. 2019. PMID: 30674441 Free PMC article.

Regulators of Oncogenic Mutant TP53 Gain of Function.

Yamamoto S, Iwakuma T. Yamamoto S, et al. Cancers (Basel). 2018 Dec 20;11(1):4. doi: 10.3390/cancers11010004. Cancers (Basel). 2018. PMID: 30577483 Free PMC article. Review.

MTBP inhibits the Erk1/2-Elk-1 signaling in hepatocellular carcinoma.

Ranjan A, Iyer SV, Ward C, Link T, Diaz FJ, Dhar A, Tawfik OW, Weinman SA, Azuma Y, Izumi T, Iwakuma T. Ranjan A, et al. Oncotarget. 2018 Apr 20;9(30):21429-21443. doi: 10.18632/oncotarget.25117. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765550 Free PMC article.

Emerging Non-Canonical Functions and Regulation of p53.

Ranjan A, Iwakuma T. Ranjan A, et al. Int J Mol Sci. 2018 Mar 28;19(4):1015. doi: 10.3390/ijms19041015. Int J Mol Sci. 2018. PMID: 29597309 Free PMC article.

Comparative oncology approach to drug repurposing in osteosarcoma.

Parrales A, McDonald P, Ottomeyer M, Roy A, Shoenen FJ, Broward M, Bruns T, Thamm DH, Weir SJ, Neville KA, Iwakuma T, Fulbright JM. Parrales A, et al. PLoS One. 2018 Mar 26;13(3):e0194224. doi: 10.1371/journal.pone.0194224. eCollection 2018. PLoS One. 2018. PMID: 29579058 Free PMC article.

The interplay between mutant p53 and the mevalonate pathway.

Parrales A, Thoenen E, Iwakuma T. Parrales A, et al. Cell Death Differ. 2018 Mar;25(3):460-470. doi: 10.1038/s41418-017-0026-y. Epub 2017 Dec 13. Cell Death Differ. 2018. PMID: 29238070 Free PMC article. Review.

Regulation of cytotoxic T-cell responses by p53 in cancer.

Braun MW, Iwakuma T. Braun MW, et al. Transl Cancer Res. 2016 Dec;5(6):692-697. doi: 10.21037/tcr.2016.11.76. Transl Cancer Res. 2016. PMID: 28944167 Free PMC article.

Nischarin inhibition alters energy metabolism by activating AMP-activated protein kinase.

Dong S, Baranwal S, Garcia A, Serrano-Gomez SJ, Eastlack S, Iwakuma T, Mercante D, Mauvais-Jarvis F, Alahari SK. Dong S, et al. J Biol Chem. 2017 Oct 13;292(41):16833-16846. doi: 10.1074/jbc.M117.784256. Epub 2017 Aug 24. J Biol Chem. 2017. PMID: 28842496 Free PMC article.

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma.

Kundu AK, Iyer SV, Chandra S, Adhikari AS, Iwakuma T, Mandal TK. Kundu AK, et al. PLoS One. 2017 Jun 21;12(6):e0179168. doi: 10.1371/journal.pone.0179168. eCollection 2017. PLoS One. 2017. PMID: 28636657 Free PMC article.

Unsaturated fatty acids regulate stemness of ovarian cancer cells through NF-κB.

Parrales A, Ranjan A, Iwakuma T. Parrales A, et al. Stem Cell Investig. 2017 Jun 3;4:49. doi: 10.21037/sci.2017.05.07. eCollection 2017. Stem Cell Investig. 2017. PMID: 28607923 Free PMC article. No abstract available.

RIPK1-TRAF2 interplay on the TNF/NF-κB signaling, cell death, and cancer development in the liver.

Yamamoto S, Iwakuma T. Yamamoto S, et al. Transl Cancer Res. 2017 May;6(Suppl 3):94-109. doi: 10.21037/tcr.2017.04.01. Transl Cancer Res. 2017. PMID: 30123738 Free PMC article. No abstract available.

Suppressive roles of A3AR and TMIGD3 i1 in osteosarcoma malignancy.

Ranjan A, Iyer SV, Iwakuma T. Ranjan A, et al. Cell Cycle. 2017 May 19;16(10):903-904. doi: 10.1080/15384101.2017.1308153. Epub 2017 Mar 29. Cell Cycle. 2017. PMID: 28355102 Free PMC article. No abstract available.

Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.

Sasaki K, Kurahara H, Young ED, Natsugoe S, Ijichi A, Iwakuma T, Welch DR. Sasaki K, et al. Clin Exp Metastasis. 2017 Apr;34(3-4):229-239. doi: 10.1007/s10585-017-9840-3. Epub 2017 Mar 13. Clin Exp Metastasis. 2017. PMID: 28289921 Free PMC article.

Roles of p53 in extrinsic factor-induced liver carcinogenesis.

Link T, Iwakuma T. Link T, et al. Hepatoma Res. 2017;3:95-104. doi: 10.20517/2394-5079.2017.07. Epub 2017 Jun 6. Hepatoma Res. 2017. PMID: 30123836 Free PMC article.

p53 as a Regulator of Lipid Metabolism in Cancer.

Parrales A, Iwakuma T. Parrales A, et al. Int J Mol Sci. 2016 Dec 10;17(12):2074. doi: 10.3390/ijms17122074. Int J Mol Sci. 2016. PMID: 27973397 Free PMC article. Review.

Non-Canonical Cell Death Induced by p53.

Ranjan A, Iwakuma T. Ranjan A, et al. Int J Mol Sci. 2016 Dec 9;17(12):2068. doi: 10.3390/ijms17122068. Int J Mol Sci. 2016. PMID: 27941671 Free PMC article. Review.

Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression.

Iyer SV, Ranjan A, Elias HK, Parrales A, Sasaki H, Roy BC, Umar S, Tawfik OW, Iwakuma T. Iyer SV, et al. Nat Commun. 2016 Nov 25;7:13561. doi: 10.1038/ncomms13561. Nat Commun. 2016. PMID: 27886186 Free PMC article.

DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.

Parrales A, Ranjan A, Iyer SV, Padhye S, Weir SJ, Roy A, Iwakuma T. Parrales A, et al. Nat Cell Biol. 2016 Nov;18(11):1233-1243. doi: 10.1038/ncb3427. Epub 2016 Oct 24. Nat Cell Biol. 2016. PMID: 27775703 Free PMC article.

Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.

Kurahara H, Bohl C, Natsugoe S, Nishizono Y, Harihar S, Sharma R, Iwakuma T, Welch DR. Kurahara H, et al. Int J Cancer. 2016 Aug 1;139(3):628-38. doi: 10.1002/ijc.30110. Int J Cancer. 2016. PMID: 27012470 Free PMC article.

Targeting Oncogenic Mutant p53 for Cancer Therapy.

Parrales A, Iwakuma T. Parrales A, et al. Front Oncol. 2015 Dec 21;5:288. doi: 10.3389/fonc.2015.00288. eCollection 2015. Front Oncol. 2015. PMID: 26732534 Free PMC article. Review.

Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis.

Ranjan A, Bera K, Iwakuma T. Ranjan A, et al. Hepatoma Res. 2016;2:114-121. doi: 10.20517/2394-5079.2015.67. Epub 2016 May 6. Hepatoma Res. 2016. PMID: 28944296 Free PMC article.

Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.

Iyer SV, Parrales A, Begani P, Narkar A, Adhikari AS, Martinez LA, Iwakuma T. Iyer SV, et al. Oncotarget. 2016 Feb 2;7(5):5401-15. doi: 10.18632/oncotarget.6634. Oncotarget. 2016. PMID: 26700961 Free PMC article.

An improved intrafemoral injection with minimized leakage as an orthotopic mouse model of osteosarcoma.

Sasaki H, Iyer SV, Sasaki K, Tawfik OW, Iwakuma T. Sasaki H, et al. Anal Biochem. 2015 Oct 1;486:70-4. doi: 10.1016/j.ab.2015.06.030. Epub 2015 Jun 30. Anal Biochem. 2015. PMID: 26142221 Free PMC article.

MTBP inhibits migration and metastasis of hepatocellular carcinoma.

Bi Q, Ranjan A, Fan R, Agarwal N, Welch DR, Weinman SA, Ding J, Iwakuma T. Bi Q, et al. Clin Exp Metastasis. 2015 Apr;32(4):301-11. doi: 10.1007/s10585-015-9706-5. Epub 2015 Mar 11. Clin Exp Metastasis. 2015. PMID: 25759210 Free PMC article.

Page of 1

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results